Pharma Shares Experience 3% Gain Amid Strong Q4 Performance

Sudarshan Pharma Sees 44.8% Profit Jump in Q4

Shares of specialty chemicals company Sudarshan Pharma rose up to 3 percent on Monday following the release of its financial results for the January–March quarter of FY26. The company's stock has been on an upward trend for the past two sessions, with shares trading higher at Rs 31 per share on the NSE, up 2.45 percent.

The financial results revealed a significant increase in profit for the March quarter, with a 44.8 percent jump to Rs 10.73 crore, compared to Rs 7.41 crore in the corresponding period last year. Revenue also saw a substantial rise, increasing by 37 percent to Rs 221 crore in Q4, up from Rs 162 crore in the same period last year. Sales during the quarter rose 36.72 percent to Rs 220.92 crore from Rs 161.59 crore a year ago.

Looking at the full fiscal year 2026, the company's net profit climbed 55.64 percent to Rs 233 million (approximately USD 1.3 billion), as against Rs 149.7 million (approximately USD 1.4 billion) in the previous year.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

In a broader market trend, benchmark equity indices Sensex and Nifty rallied sharply on Monday, supported by easing crude oil prices, firm global cues, and buying in auto shares.